Nanotecnología aplicada a la medicina
Nerlis Pájaro Castro
Universidad de Cartagena
Jesús Olivero Verbel
Universidad de Cartagena
Juan Redondo Padilla
Universidad de Cartagena
PDF

Palabras clave

nanomedicina
nanociencia
nanomateriales
PDF

Resumen

La nanotecnología comprende la creación, manipulación y utilización de materiales en el orden nanométrico (10-9 m) y su aplicación en los campos de la química, la biología, la física, la ingeniería y en especial la medicina, se ha traducido en trascendentales avances en la ciencia. La hoy denominada nanomedicina ha comportado significativos adelantos en la monitorización, la reparación de tejidos, el diagnostico, el tratamiento y la prevención de enfermedades mediante el uso de herramientas como nanosensores, nanopartículas y nanotubos, y en el futuro cercano nanorrobots capaces de penetrar en el organismo humano para repararlo. La nanotecnología se encuentra en una fase de crecimiento y ha capturado el interés de empresas, gobiernos e inversionistas que buscan desarrollar productos útiles para aplicarlos en diferentes esferas, especialmente en medicina.

PDF

Citas

ARGENTINA. Ministerio de Ciencia, Tecnología e Innovación Productiva. Boletín estadístico tecnológicoNo.3.2009. http://www.mincyt.gov.ar/admin/multimedia/archivo/archivos/BET_Nanotecnologia.pdf. Consultado el: 10-11-2010.

ARORA, S., RAJWADE, J.M., PAKNIKAR, K.M. (2012). “Nanotoxicology and in vitro studies: the need of the hour”. En Toxicol Appl Pharmacol. 258(2), pp 151-165.

BOISSEAU, P., LOUBATONB, B. (2011). “Nanomedicine, nanotechnology in medicine”. En CR Physique. 12(7), pp 620-636.

BOUWMEESTER, H., DEKKERS, S., NOORDAM, M., HAGENS, W., BULDER, A., DE HEER, C., TEN VOORDE, S.E., WIJNHOVEN, S.W., MARVIN, H.J., SIPS, A.J. (2009). “Review of health safety aspects of nanotechnologies in food production”. En Regul Toxicol Pharmacol. 53(1), pp 52-62.

COLON, J., HSIEH, N., FERGUSON, A., KUPELIAN, P., SEAL, S., JENKINS, D., BAKER, C.H. (2010). “Cerium oxide nanoparticles protect gastroIntestinal epithelium from radiation-induced damage by reduction of ROS and upregulation of super oxide dismutase-2”. En Nanomedicine: NBM. 6(5), pp 698-705.

OPPO, J. (2009). “Nanotecnología, medicina veterinaria y producción agropecuaria”. En Rev Vet. 20(1), pp 61-71.

ETHERIDGE, M.L., CAMPBELL, S.A., ERDMAN, A.G., HAYNES, C.L., WOLF, S.M., MCCULLOUGH, J. (2013). “The big picture on nanomedicine: the state of investigational and approved nanomedicine products”. En Nanomedicine. 9(1), pp 1-14.

FARRÉ, M., GAJDA-SCHRANTZ, K., KANTIANI, L., BARCELÓ, D. (2009). “Ecotoxicity and analysis of nanomaterials in the aquatic environment”. En Anal Bioanal Chem. 393(1), pp 81-95.

FEDOROVICH, S., ALEKSEENKO, A., WASEEM, T. (2010). “Are synapses targets of nanoparticles?” .En Biochem Soc Trans. 38(2), 536-538.

FREITAS R. (2005). “What is nanomedicine?”. En Nanomedicine: NBM. 1(1), pp 2-9.

GARCÍA, J. (2008). “Nanotecnología: un sector estratégico en innovación y creación de valor”. En Economía Exterior. 44, pp 8–22. Disponible en: http://t3innovacion.larioja.org/uploads/media/Innovacion-Nanotecnologia.pdf. Consultado el: 25-09-2010.

GAJEWICZ, A., RASULEV, B., DINADAYALANE, T.C., URBASZEK, P., PUZYN, T., LESZCZYNSKA, D., LESZCZYNSKI, J. (2012). “Advancing risk assessment of engineered nanomaterials: Application of computational approaches”. En Adv Drug Deliv Rev. 64(15), pp 1663-1693.

GODIN, B., SAKAMOTO, J., SERDA R, GRATTONI, A., BOUAMRANI, A., FERRARI, M. (2010). “Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases”. En Trends Pharmacol Sci. 31(5), pp 199-205.

GOMMERSALL, L., SHERGILL, I., AHMED, H., HAYNE, D., ARYA, M., PATEL, H., HASHIZUME, M., GILL, I.S. (2007). “Nanotechnology and its relevance to the urologist”. En Eur Urol. 52(2), pp 368-375.

HAES, A., CHANG, L., KLEIN, W., VAN DUYNE, R. (2005). “Detection of a biomarker for Alzheimer’s disease from synthetic and clinical samples using a nanoscale optical biosensor”. En J Am Chem Soc. 127(7), pp 2264-2271.

HAMZELOU, J. (2012). “DNA origami nanorobot takes drug direct to cancer cell”. En The New Scientist. 213(2853), p. 9.

INVERNIZZI, N., FOLADORI, G. (2005). “El despegue de las nanotecnologías”. En Ciencia ergo sum. 12(3), pp 321-327.

JOSEPH, P., COTTIN-BIZONNE, C., BENOÎT, J.M., YBERT, C., JOURNET, C., TABELING, P., BOCQUET, L. (2006). “Slippage of water past superhydrophobic carbon nanotube forests in microchannels”. En Phys Rev Lett. 97(15), pp 156104-1-156104-4.

KANNANGAI, R., ABRAHAM, A.M., SANKAR, S., SRIDHARAN, G. (2010). “Nanotechnology tools for single-virus particle detection”. En Indian J Med Microbiol. 28(2), pp 95-99.

KEWAL, J. (2005). “Nanotechnology in clinical laboratory diagnostics”. En Clin Chim Acta. 358(1-2), pp 37-54.

KIM, K. (2007). “Nanotechnology platforms and physiological challenges for cancer therapeutics”. En Nanomedicine: NBM. 3(2), pp 103-110.

KUBINOVÁ, S., SYKOVÁ, E. (2010). “Nanotechnology for treatment of stroke and spinal cord injury”. En Nanomedicine (Lond). 5(1), pp 99-108.

LAOCHAROENSUK, R., BURDICK, J., WANG, J. (2008). “Carbon-nanotube-induced acceleration of catalytic nanomotors”. En ACS Nano. 2(5), pp 1069-1075.

LARA, H., AYALA, N., IXTEPAN, L., RODRÍGUEZ, C. (2010). “Mode of antiviral action of silver nanoparticles against HIV-1”. En J Nanobiotechnol. 8:1.

LEE, Y., KOPELMAN, R., SMITH, R. (2009). “Nanoparticle PEBBLE sensors in live cells and in vivo”. En Annu. Rev Anal Chem. 2, pp 57-76.

LI, J., ZHANG, J. (2009). “Optical properties and applications of hybrid semiconductor nanomaterials”. En Coord Chem Rev. 253(23-24), pp 3015-3041.

LIN, C., LIU, Y., YAN, H. (2009). “Designer DNA nanoarchitectures”. En Biochemistry. 48(8), pp 1663-1674.

MAMO, T., MOSEMAN, E., KOLISHETTI, N., SALVADOR, C., SHI, J., KURITZKES, D., LANGER, R., VON ANDRIAN, U., FAROKHZAD, O.C. (2010). “Emerging nanotechnology approaches for HIV/ AIDS treatment and prevention”. En Nanomedicine (Lond). 5(2), pp 269-285.

MANGEMATIN, V., WALSH, S. (2012). “The future of nanotechnologies”. En Technovation. 32(3-4), pp 157-160

MASOTTI, A., ORTAGGI, G. (2009). “Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery”. En Mini Rev Med Chem. 9(4), pp 463-469.

MOROSE, G. (2010). “The 5 principles of “designer for safer nanotechnology”. En J Clean Prod. 18(3), pp 285-289.

MURDAY, J., SIEGEL, R., STEI, J., WRIGHT, F. (2009). “Translational nanomedicine: status assessment and opportunities”. En Nanomedicine: NBM. 5(3), pp 251-273.

OZPOLAT, B., SOOD, A., LOPEZ-BERESTEIN, G. (2009). “Nanomedicine based approaches for the delivery of siRNA in cancer”. En J Intern Med. 267(1), pp 44-53.

PASTRANA, H., AVILA, A. (2006). “Nanomedicina: Estado del arte”. En Revista de Ingeniería Universidad de los Andes. 25, pp 60-69.

PATOLSKY, F., ZHENG, G., LIEBER, C. (2006). “Nanowire sensors for medicine and the life sciences”. En Nanomedicine (Lond). 1(1), pp 51-65.

PORCEL, E., LIEHN, S., REMITA, H., USAMI, N., KOBAYASHI, K., FURUSAWA, Y., LE SECH, C., LACOMBE, S. (2010). “Platinum nanoparticles: a promising material for future cancer therapy?”. En Nanotechnology. 21(8), pp 85-103.

POWERS, K.W., BROWN, S.C., KRISHNA, V.B., WASDO, S.C., MOUDGIL, B.M., ROBERTS, S.M. (2005). “Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation”. En Toxicol Sci. 90(2), pp 296-303.

PICKUP, J., ZHI, Z., KHAN, F., SAXL, T., BIRCH, D. (2008). “Nanomedicine and its potential in diabetes research and practice”. En Diabetes Metab. Res Rev. 24(8), pp 604-610.

PUURUNEN, K., VASARA, P. (2007). “Opportunities for utilising nanotechnology in reaching near-zero emissions in the paper industry”. En J Clean Prod. 15(13-14), pp 1287-1294.

QI, L., ZHENG, S., LIN, B. (2010). “Recent patents on imaging nanoprobes for brain tumor diagnosis and therapy”. En Recent Pat Biotechnol. 14(2), pp 130-135.

ROCO, M. (2003). “Nanotechnology: convergence with modern biology and medicine”. En Curr Opin Biotechnol. 14(3), pp 337-346.

ROMIG, A., BAKER, A., JUSTINE, J., ZIPPERIAN, T., EIJKEL, K., KIRCHHOFF, B., MANI, H.S., RAO, C.N.R., WALSH, S. (2007). “An introduction to nanotechnology policy: Opportunities and constraints for emerging and established economies”. En Technol Forecast Soc Change. 74(9), pp 1634-1642.

SAHOO, S., PARVEEN, S., PANDA, J. (2007). “The present and future of nanotechnology in human health care”. En Nanomedicine: NBM. 3(1), pp 20-31.

SÁNCHEZ J. (2007). “Los tejidos inteligentes y el desarrollo tecnológico de la industria textil”. En Técnica industrial. 268, pp 38-45. Disponible en: http://www.tecnicaindustrial.es/TIAdmin/Numeros/28/36/a36.pdf. Consultado el: 19-08-2010.

SÁNCHEZ, S., PUMERA, M. (2009). “Nanorobots: the ultimate wireless self-propelled sensing and actuating devices”. En Chem Asian J. 4(9), pp 1402-1410.

SERRANO, E., RUS, G., GARCÍA, J. (2009). “Nanotechnology for sustainable energy”. En Renew Sust Energ Rev. 13(9), pp 2373-2384.

SILVA, G. (2004). “Introduction to nanotechnology and its applications to medicine”. En Surg Neurol. 61(3), pp 216-220.

SLEVIN, M., BADIMON, L., GRAU-OLIVARES, M., RAMIS, M., SENDRA, J., MORRISON, M., KRUPINSKI, J. (2010). “Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis”. En Mol Biosyst. 6(3), pp 444-450.

TYLIOS, K., GIANNOUDIS, V., WAN, T. (2005). “Applications of nanotechnologies in medical practice”. En Injury, Int J Care Inju. 36(4), pp S6-S13.

SUH, W.H., SUSLICK, K.S., STUCKY, G.D., SUH, Y.H. (2009). “Nanotechnology, nanotoxicology, and neuroscience”. En Prog Neurobiol. 87(3), pp 133-70.

SURENDIRAN, A., SANDHIYA, S., PRADHAN, S., ADITHAN, C. (2009). “Novel applications of nanotechnology in medicine”. En Indian J Med Res. 130(6), pp 689-701.

TELI, M., MUTALIK, S., RAJANIKANT, G. (2010). “Nanotechnology and nanomedicine: Going small means aiming big”. En Curr Pharm Des. 16(16), pp 1882-1892.

THOMAS, T., BAHADORI, T., SAVAGE, N., THOMAS, K. (2009). “Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions”. En Wiley Interdiscip Rev Nanomed Nanobiotechnol. 1(4), pp 426-433.

VENUGOPAL, J., PRABHAKARAN, M., ZHANG, Y., LOW, S., CHOON, A., RAMAKRISHNA, S. (2010). “Biomimetic hydroxyapatite-containing composite nanofibrous substrates for bone tissue engineering”. En Philos Transact A Math Phys Eng Sci. 368(1917), pp 2065-2081.

WANG, J. (2009). “Can man-made nanomachines compete with nature biomotors?”. En ACS Nano. 3(1), pp 4-9.

WONG, H.L., WU, X.Y., BENDAYAN, R. (2012). “Nanotechnological advances for the delivery of CNS therapeutics”. En Adv Drug Deliv Rev. 64(7), pp 686-700.

ZARBIN, M.A., MONTEMAGNO, C., LEARY, J.F., RITCH, R. (2012). “Regenerative nanomedicine and the treatment of degenerative retinal diseases”. En Wires Nanomed Nanobiotechnol. 4(1):113-137.

ZHANG, L., WEBSTER, T. (2009). “Nanotechnology and nanomaterials: Promises for improved tissue regeneration”. En Nano Today. 4(1), pp 66-80.

ZHANG, X.D., WU, D., SHEN, X., CHEN, J., SUN, Y.M., LIU, P.X., LIANG, X.J. (2012). “Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy”. En Biomaterials. 33(27):6408-6419.

ZHAO, L., WANG, Z., FAN, S., MENG, Q., LI, B., SHAO, S., WANG, Q. (2010). “Chemotherapy resistance research of lung cancer based on micro-fluidic chip system with flow medium”. En Biomed Microdevices. 12(2), pp 325-332.

Creative Commons License
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-CompartirIgual 4.0.

 

The Journal Guillermo de Ockham provides an immediate and open access to its content, based on the principle of offering the public a free access to investigations to provide a global interchange of knowledge.

Unless otherwise established, the contents of this journal has a license with Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) http://creativecommons.org/licenses/by-nc-nd/4.0/

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.